This is not the most recent version of the article. View current version (22 MAY 2014)

Intervention Review

You have free access to this content

Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis

  1. Karen A Robinson1,*,
  2. Olaide A Odelola2,
  3. Ian J Saldanha3,
  4. Naomi A Mckoy4

Editorial Group: Cochrane Cystic Fibrosis and Genetic Disorders Group

Published Online: 5 JUN 2013

Assessed as up-to-date: 17 APR 2013

DOI: 10.1002/14651858.CD007743.pub4


How to Cite

Robinson KA, Odelola OA, Saldanha IJ, Mckoy NA. Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis. Cochrane Database of Systematic Reviews 2013, Issue 6. Art. No.: CD007743. DOI: 10.1002/14651858.CD007743.pub4.

Author Information

  1. 1

    Johns Hopkins University, Department of Medicine, Baltimore, MD, USA

  2. 2

    Albert Einstein Medical Center, Department of Internal Medicine, Philedelphia, PA, USA

  3. 3

    Johns Hopkins Bloomberg School of Public Health, Department of Epidemiology, Baltimore, MD, USA

  4. 4

    Human Genome Sciences, Inc., SSM Microbial Upstream Common Use Production, Rockville, Maryland, USA

*Karen A Robinson, Department of Medicine, Johns Hopkins University, 1830 E. Monument St., Suite 8068, Baltimore, MD, 21287, USA. krobin@jhmi.edu.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 5 JUN 2013

SEARCH

This is not the most recent version of the article. View current version (22 MAY 2014)

  1. Current Version

    Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis

    Karen A Robinson, Olaide A Odelola and Ian J Saldanha

    Article first published online: 22 MAY 2014 | DOI: 10.1002/14651858.CD007743.pub5

Previous versions of this article and their online publication dates

  1. You have free access to this content

    Version 4

    Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis

    Karen A Robinson, Olaide A Odelola, Ian J Saldanha and Naomi A Mckoy

    Article first published online: 5 JUN 2013 | DOI: 10.1002/14651858.CD007743.pub4

  2. Version 3

    Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis

    Karen A Robinson, Olaide A Odelola, Ian J Saldanha and Naomi A Mckoy

    Article first published online: 15 FEB 2012 | DOI: 10.1002/14651858.CD007743.pub3

  3. Version 2

    Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis

    Karen A. Robinson, Olaide A Odelola, Ian Saldanha and Naomi Mckoy

    Article first published online: 17 FEB 2010 | DOI: 10.1002/14651858.CD007743.pub2

  4. Version 1

    Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis

    Karen A. Robinson, Olaide A Odelola, Ian Saldanha and Naomi Mckoy

    Article first published online: 15 APR 2009 | DOI: 10.1002/14651858.CD007743